Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McGovern

Showing results (301-310 of 342) with videos related to

Pageof 35
Sort By:
Clinical and Translational Science|August 11, 2021
Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney functionJason N Barreto, Joel M Reid, Carrie A Thompson, et al.
Journal of Occupational and Environmental Medicine|February 25, 2011
Violence against educators: a population-based studySusan G Gerberich, Nancy M Nachreiner, Andrew D Ryan, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Journal of Medical Economics|October 11, 2023
Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in JapanIsao Kamae, Yue Zhong, Hidehiko Hara, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2009
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory reportIra M Lubin, Margaret M McGovern, Zoe Gibson, et al.
Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Obesity (Silver Spring, Md.)|October 7, 2017
Associations of Maternal Weight Status Before, During, and After Pregnancy with Inflammatory Markers in Breast MilkKara M Whitaker, Regina C Marino, Jacob L Haapala, et al.
Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.
Pageof 35

Showing results (301-310 of 342) with videos related to

Sort By:
Pageof 35
Clinical and Translational Science|August 11, 2021
Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney functionJason N Barreto, Joel M Reid, Carrie A Thompson, et al.
Journal of Occupational and Environmental Medicine|February 25, 2011
Violence against educators: a population-based studySusan G Gerberich, Nancy M Nachreiner, Andrew D Ryan, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Journal of Medical Economics|October 11, 2023
Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in JapanIsao Kamae, Yue Zhong, Hidehiko Hara, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2009
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory reportIra M Lubin, Margaret M McGovern, Zoe Gibson, et al.
Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Obesity (Silver Spring, Md.)|October 7, 2017
Associations of Maternal Weight Status Before, During, and After Pregnancy with Inflammatory Markers in Breast MilkKara M Whitaker, Regina C Marino, Jacob L Haapala, et al.
Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.
Pageof 35